Success Story: How a Medical Science Expert Won NIW Approval in over 13 Months without RFE
Client’s Testimonial:
"Thank you so much! I truly appreciate all of your help throughout the process."
On May 2nd, 2026, we received an EB-2 NIW (National Interest Waiver) Approval for an Epidemiologist and Lead Investigator in the Field of Medical Science (Approval Notice).
General Field: Medical Science
Position at the Time of Case Filing: Epidemiologist and Lead Investigator
Approval Notice Date: May 1st, 2026
Processing Time: over 13 months
Case Summary:
An EB-2 NIW petition was recently approved after over 13 months without an RFE for an epidemiologist and lead investigator with a Ph.D. in engineering sciences, biomedical engineering, whose pioneering research in bioinformatics and molecular epidemiology is transforming early detection and prevention strategies for ovarian cancer, one of the most lethal yet diagnostically elusive cancers affecting women in the United States.
Research Leadership and National Impact
With a career built at the intersection of bioinformatics, metabolomics, and cancer epidemiology, this researcher has become a recognized authority in applying multi-omics analytical methods to uncover novel disease biomarkers and risk factors. The proposed endeavor is to use bioinformatic techniques to better identify and validate novel risk factors and early biomarkers for ovarian cancer in order to improve prevention and early detection strategies, particularly for high-risk individuals, addressing a profound and urgent public health need across the nation.
Ovarian cancer remains one of the most devastating and difficult-to-detect cancers affecting women in the United States, with the vast majority of cases diagnosed only at advanced stages when treatment options are significantly limited. The groundbreaking identification of novel metabolic risk factors and early biomarkers for this disease holds the potential to shift this paradigm, improving population-level screening, enabling earlier intervention, and ultimately saving lives across the country.
The scholarly record reflects exceptional productivity and scientific influence:
- 68 peer-reviewed journal articles (11 of them first-authored)
- Nearly 2000 citations from researchers across the global scientific community, reflecting the breadth and depth of this work's real-world influence
- At least 60 peer reviews completed for prestigious venues
- Major research funding from organizations of exceptional national prestige, including the Amazon AWS Cloud Credits for Research, the National Cancer Institute, the COMET Programme, the Royal National Institute for Deaf People, the National Institute on Deafness and Other Communication Disorders, and the Department of Defense's Ovarian Cancer Research Program
Expert Endorsements
To strengthen the NIW filing, our firm included 4 expert recommendation letters from independent scholars who have directly cited and built upon this research in their own work. One recommender stated:
"Ensuring that [Client]'s work proceeds is thus not only important to the field, but to the United States as well."
NIW Approval and Outlook
This NIW approval reflects USCIS's recognition of a leading figure in medical science whose multi-omics research has direct and lasting applications to U.S. public health outcomes. The approval validates sustained impact, exceptional ability, and clear future benefit to the United States in advancing ovarian cancer prevention, improving early detection strategies, and enhancing the analytical tools that power the next generation of cancer and epidemiological research.
It has been an honor to support this exceptional researcher throughout the petition process, and we extend our sincere best wishes for continued success in both professional and personal pursuits. We look forward to witnessing the continued breakthroughs this work will bring in protecting the health and lives of Americans for years to come.